Zobrazeno 11 - 20
of 281
pro vyhledávání: ''
Autor:
Giovanni Randon, Marco Maccauro, Melanie Claps, Filippo Pagani, Giulia Apollonio, Giorgia Peverelli, Giuseppe Procopio, Gianluca Aliberti, Alessandra Raimondi, Ettore Seregni, Pierangela Sepe, Elena Verzoni
Publikováno v:
Tumori Journal. 106:406-412
Introduction: Therapeutic decision-making in metastatic castration-resistant prostate cancer (mCRPC) represents an open challenge. Radium-223 is approved for patients with symptomatic bone metastases, no visceral involvement, progressing after at lea
Autor:
Claudio Zamagni, A. Marino, Gianfranco Filippelli, Claudio Scavelli, Caterina Fontanella, Antonio Febbraro, Anna Maria Quaranta, Pasqualinda Ferrara, Paola Schiavone, Laura Orlando, Palma Fedele, Eufemia Stefania Lutrino, Guido Giordano, Gianluca Dima, Chiara Caliolo, Nicola Calvani, Saverio Cinieri, Mariangela Giampaglia, Daniela Rubino, Domenico Bilancia
Publikováno v:
Tumori
Background: Chemotherapy plus targeted therapy is the established treatment for human epidermal growth factor receptor 2 (HER2)–overexpressing breast cancer (BC). Limited data regarding the safety and activity of the combination of eribulin and tra
Autor:
Philippe Schafhausen, Carsten Bokemeyer, Judith Dierlamm, Frank Dicker, Snjezana Janjetovic, Anne Marie Asemissen, Mascha Binder
Publikováno v:
Tumori Journal. 105:NP8-NP11
Background: Progression of chronic myeloid leukemia (CML) is frequently accompanied by cytogenetic evolution, with an extra copy of the Philadelphia chromosome, trisomy 8 and 19, and isochromosome (17p) commonly detected. Translocations involving 11q
Autor:
Lonardi, S., Nasti, G., Fagnani, D., Gemma, D., Ciuffreda, L., Granetto, C., Lucchesi, S., Ballestrero, A., Biglietto, M., Proserpio, I., Bergamo, F., Proietti, E., Tonini, G., Soto Parra, H
Publikováno v:
Tumori Journal. 105:243-252
Aims: BEAWARE investigated the pattern of first-line bevacizumab early interruption in the Italian real-world setting of metastatic colorectal cancer. Methods: A total of 386 patients were followed for 15 months after first-line chemotherapy + bevaci
Publikováno v:
Tumori Journal. 106:87-94
Colorectal cancer, one of the most frequent types of cancer worldwide, has a high mortality rate. Irinotecan (CPT-11) has been approved for the treatment of advanced or metastatic disease either as a single agent or, more commonly, as part of combine
Autor:
Giorgio de Stefano, Arianna Lanzi, Oronzo Brunetti, Daniele Bruno, Francesca Negri, Luca Faloppi, Umberto Vespasiani Gentilucci, Flavia Pagan, Giovanni Luca Frassineti, Marianna Silletta, Mario Scartozzi, Vittorina Zagonel, Daniele Santini, Andrea Casadei Gardini, Luchino Chessa, Vincenzo Dadduzio, Giorgia Marisi, Francesco Giuseppe Foschi, Stefano Cascinu, Emiliano Tamburini, Nicola Silvestris, Gianluca Masi, Lorenzo Calvetti, Giorgio Ercolani, Caterina Vivaldi, Chiara Caparello, Alessandro Leonetti, Giuseppe Aprile, N. Farella, Emanuela Scarpi, Davide Tassinari, Jody Corbelli
Publikováno v:
Tumori Journal. 104:476-479
Introduction: Although sorafenib is the upfront standard of care for advanced hepatocellular carcinoma (HCC), molecular predictors of efficacy have not been identified yet. In the ALICE-1 study, rs2010963 of VEGF-A and VEGF-C proved to be independent
Colorectal cancer and brain metastases: An aggressive disease with a different response to treatment
Autor:
Pamela Freiha, Abir El-Ahmadie, Khalil Saleh, Lionel El-Khoury, Tony Felefly, Nadine Khalife-Saleh, Georges Chahine, Tony Ibrahim
Publikováno v:
Tumori Journal. 105:427-433
Introduction: Brain metastases (BM) are rare in colorectal cancer (CRC) and are associated with a dismal prognosis. This work aims to report the rate of BM in CRC patients treated in a single institution, along with survival and prognostic factors. M
Autor:
Fabio Calabrò, Christophe Massard, Michel Ducreux, Lukas Heukamp, Todd Hembrough, Anas Gazzah, Patrizia Trenta, Jean-Charles Soria, Diane Goéré, Cora N. Sternberg, Ludovic Lacroix, Rastislav Bahleda, Maximiliano Gelli, Julien Adam, Fabiola Cecchi, Linda Mahjoubi, Philippe Jamme
Publikováno v:
Tumori Journal. 104:NP38-NP41
Introduction: Diffuse gastric cancer is associated with poor prognosis. We report a patient with metastatic gastric linitis plastica harboring human epidermal growth factor receptor 2 ( HER2) activating mutation and HER2 amplification. Case descripti
Autor:
Gabriella Saibene, Franco Berrino, Anna Villarini, Giuliana Gargano, Alice Casagrande, Maria Gaetana Di Mauro, Patrizia Pasanisi, Elisabetta Venturelli, Eliana Roveda, Mauro Cortellini, Eleonora Bruno
Publikováno v:
Tumori Journal. 104:137-142
Purpose: Age-related non-communicable chronic diseases (ArCDs) are the leading cause of mortality. The major metabolic risk factor for their development is the metabolic syndrome (MetS), defined as a clustering of risk factors of metabolic origin suc
Autor:
Giorgia Peverelli, Paolo Grassi
Publikováno v:
Tumori Journal. 103:S56-S59
Purpose Pure small cell neuroendocrine carcinoma of the prostate is a rare entity characterized by a poor prognosis due to early metastatic spread as well as resistance to treatment. Considering its increasing occurrence, clinicians should be aware o